A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine in Healthy Male Volunteers

Trial Profile

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2016

At a glance

  • Drugs Amlodipine/rosuvastatin/telmisartan (Primary)
  • Indications Cardiovascular disorders
  • Focus Pharmacokinetics
  • Sponsors Jeil Pharmaceutical
  • Most Recent Events

    • 23 Jun 2016 Primary endpoints assessed at 72 hours and 144 hours (previously they were assessed at only 144 hours).
    • 21 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top